Final answer:
Excess nonsterile compounds should be labeled with beyond-use dating, lot number, and drug name. The patient's name is not required unless the compound is specifically designated for a particular individual's use.
Step-by-step explanation:
When labeling excess nonsterile compounds for future use, there is a specific piece of information that is not required to be included: the patient's name. This is because the compound is not yet designated for a specific patient. However, the following details must always be included:
- Beyond-use dating, to ensure that the compound is used before it becomes less effective or hazardous.
- The lot number, which helps in tracking the batch of the compound and is crucial in case of a recall or identifying issues with a specific manufacturing run.
- The drug name, so healthcare providers can easily identify the compound and ensure proper usage.
It is also important to follow safety protocols, such as hand washing, to prevent the spread of contaminants, and ensure the proper disposal of hazardous materials as per the laboratory or healthcare facility's guidelines.